Related Experiment Videos
Infectious complications following breast reconstruction with expanders and implants
Maurice Y Nahabedian1, Theodore Tsangaris, Bahram Momen
1Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, USA. mnahabed@jhmi.edu
Plastic and Reconstructive Surgery
|August 6, 2003
Summary
Radiation therapy significantly increases infection risk after breast reconstruction with implants. Lymph node dissection may also elevate infection chances, highlighting key factors for patient care.
Area of Science:
- Plastic Surgery
- Oncology
- Infectious Disease
Background:
- Infection incidence after breast reconstruction with expanders and implants varies widely (1-24%).
- Previous studies identified potential infection factors but lacked comprehensive multifactorial analysis.
Purpose of the Study:
- To analyze multiple factors predisposing women to expander or implant infection following breast reconstruction.
- To determine the statistical significance of various clinical and treatment-related factors on infection rates.
Main Methods:
- Retrospective analysis of 168 implant reconstructions in 130 women (1997-2000).
- Factors analyzed included axillary lymph node dissection, chemotherapy, radiation therapy, tumor stage, implant timing, laterality, tobacco use, and diabetes.
- Stepwise logistic regression was used for statistical analysis.
Main Results:
- Infectious complications occurred in 7.7% of women and 5.9% of implants.
- Radiation therapy showed a significant association (p < 0.04) with implant infection (4.88 times higher risk).
- Lymph node dissection showed suggestive evidence (p < 0.09) of increased infection risk (6.29 times higher).
Conclusions:
- Radiation therapy is a significant risk factor for infection in breast implant reconstruction.
- Axillary lymph node dissection may also increase infection risk, warranting careful consideration.
- Age, diabetes, chemotherapy, tumor stage, implant timing, and tobacco use were not significantly associated with infection in this cohort.